scholarly journals Functional properties and features of clinical application of adipose-derived stem cells in aesthetic medicine and dermatology: a brief review

2019 ◽  
Vol 7 (2) ◽  
Author(s):  
V. Ivanishchev ◽  
Cancers ◽  
2018 ◽  
Vol 10 (11) ◽  
pp. 446 ◽  
Author(s):  
Jui-Hua Lu ◽  
Bou-Yue Peng ◽  
Chun-Chao Chang ◽  
Navneet Dubey ◽  
Wen-Cheng Lo ◽  
...  

Cancer is a leading cause of mortality and a major public health problem worldwide. For biological therapy against cancer, we previously developed a unique immunotherapeutic platform by combining mesenchymal stem cells with an antigen-specific protein vaccine. However, this system possesses a few limitations, such as improperly immortalized mesenchymal stem cells (MSCs) along with transfected oncogenic antigens in them. To overcome the limitations of this platform for future clinical application, we freshly prepared primary adipose-derived stem cells (ADSCs) and modified the E7’ antigen (E7’) as a non-oncogenic protein. Either subcutaneously co-inoculated with cancer cells or systemically administered after tumor growth, ADSC labeled with enhanced green fluorescent protein (eGFP) and combined with modified E7’ (ADSC-E7’-eGFP) cells showed significant antitumor activity when combined with the protein vaccine in both colon and lung cancer in mice. Specifically, this combined therapy inhibited tumor through inducing cell apoptosis. The significantly reduced endothelial cell markers, CD31 and vascular endothelial growth factor (VEGF), indicated strongly inhibited tumor angiogenesis. The activated immune system was demonstrated through the response of CD4+ T and natural killer (NK) cells, and a notable antitumor activity might be contributed by CD8+ T cells. Conclusively, these evidences imply that this promising immunotherapeutic platform might be a potential candidate for the future clinical application against cancer.


2014 ◽  
Vol 199 (1) ◽  
pp. 88-96 ◽  
Author(s):  
Shota Kono ◽  
Tomohiko Kazama ◽  
Koichiro Kano ◽  
Kayoko Harada ◽  
Masami Uechi ◽  
...  

2018 ◽  
Vol 4 (1) ◽  
pp. 4-19
Author(s):  
Sridhar NK ◽  
◽  
Sanjay Gottipamula ◽  
Kumar Chokalingam

2017 ◽  
Vol 16 (5) ◽  
pp. e2230
Author(s):  
K. Warda ◽  
M. Pokrywczynska ◽  
T. Kloskowski ◽  
D. Balcerczyk ◽  
M. Rasmus ◽  
...  

Author(s):  
Simona Ceccarelli ◽  
Paola Pontecorvi ◽  
Eleni Anastasiadou ◽  
Claudio Napoli ◽  
Cinzia Marchese

2018 ◽  
Vol 47 (10) ◽  
pp. 2369-2379
Author(s):  
Adila A. Hamid ◽  
Satish Vaarman Jeyabalan ◽  
Aleza Omar ◽  
Nik Zattil Hanan Mohd Yasin ◽  
Tzeng Lin Wong ◽  
...  

2019 ◽  
Vol 8 (5) ◽  
pp. 675
Author(s):  
Katarzyna Kornicka ◽  
Florian Geburek ◽  
Michael Röcken ◽  
Krzysztof Marycz

With this Editorial, we introduce the Special Issue “Adipose-Derived Stem Cells and Their Extracellular Microvesicles (ExMVs) for Tissue Engineering and Regenerative Medicine Applications” to the scientific community. In this issue, we focus on regenerative medicine, stem cells, and their clinical application.


2020 ◽  
Author(s):  
Tian-Yu Zhang ◽  
Poh-Ching Tan ◽  
Yun Xie ◽  
Xiao-Jie Zhang ◽  
Pei-Qi Zhang ◽  
...  

Abstract Background: Adipose-derived stem cells (ADSCs) promote tissue regeneration and repair. Cryoprotective agents (CPA) protect cells from cryodamage in the process of cryopreservation. Safe and efficient cryopreservation of ADSCs is critical in the clinical application of cell-based therapy. However, most CPAs contain toxic concentrations limiting the possibility of their clinical application. Objective: The aim of this study is to develop a non-toxic xeno-free CPA for ADSCs to achieve high-efficiency and low-risk cryopreservation. Methods: We explored the most efficient concentrations in different concentrations of trehalose (0.3M, 0.6M, 1.0M, and 1.25M) and glycerol (10%, 20%, 30% v/v); then evaluated the outcome of the combination of trehalose and glycerol in ADSC cryopreservation, compared to the commonly used CPA, DMSO (10%) + FBS (90%). All samples were slowly freezed and stored in liquid nitrox for 30 days. The effectiveness was evaluated by the cell viability, proliferation, migration and multi-potential differentiation of ADSCs after thawing. Results: Compared to the CPAs with single reagent, 1.0M Tre + 20%Gly group showed significantly higher efficiency in preserving ADSCs activities after thawing, with better outcome in both cell viability and proliferating capacity. Compared to 10%DMSO+90%FBS, ADSCs preserved in 1.0M Tre + 20%Gly group showed similar cell viability, surface markers and multi-potential differentiation but significantly higher migration capability, indicating that better cell function preservation can be achieved by 1.0M Tre + 20%Gly. Conclusions: 1.0M Tre + 20%Gly can preserve ADSCs with high migration capability and cell viability compared to 10%DMSO+90%FBS and maintain similar stemness and multi-potential differentiation as fresh cells. Our results demonstrate that 1.0M Tre + 20%Gly can achieve highly efficient cryopreservation of ADSCs and is suitable for clinical applications.


Sign in / Sign up

Export Citation Format

Share Document